LEVREXA Trademark

Trademark Overview

On Friday, June 8, 2007, a trademark application was filed for LEVREXA with the United States Patent and Trademark Office. The USPTO has given the LEVREXA trademark a serial number of 79041001. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, June 9, 2017. This trademark is owned by UCB PHARMA, Société Anonyme. The LEVREXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations acting on the central nervous system
levrexa

General Information

Serial Number79041001
Word MarkLEVREXA
Filing DateFriday, June 8, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, June 9, 2017
Registration Number3402154
Registration DateTuesday, March 25, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations acting on the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 31, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB PHARMA, Société Anonyme
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE
Party NameUCB PHARMA, Société Anonyme
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameUCB PHARMA, Société Anonyme
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Thursday, December 28, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, December 28, 2017DEATH OF INTERNATIONAL REGISTRATION
Friday, September 11, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, August 20, 2015GENERIC MADRID TRANSACTION SENT TO IB
Thursday, August 20, 2015GENERIC MADRID TRANSACTION CREATED
Tuesday, June 30, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 31, 2014CANCELLED SECTION 71
Saturday, December 22, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 16, 2008FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 16, 2008FINAL DISPOSITION PROCESSED
Wednesday, June 25, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 25, 2008REGISTERED-PRINCIPAL REGISTER
Monday, March 3, 2008ASSIGNED TO EXAMINER
Tuesday, January 8, 2008PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2007NOTICE OF PUBLICATION
Friday, November 30, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 30, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 28, 2007AMENDMENT FROM APPLICANT ENTERED
Wednesday, November 28, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 28, 2007ASSIGNED TO LIE
Thursday, October 25, 2007ASSIGNED TO EXAMINER
Friday, October 19, 2007PAPER RECEIVED
Friday, October 19, 2007REFUSAL PROCESSED BY IB
Monday, October 1, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 1, 2007REFUSAL PROCESSED BY MPU
Saturday, September 29, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 28, 2007NON-FINAL ACTION WRITTEN
Sunday, September 16, 2007ASSIGNED TO EXAMINER
Friday, August 24, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, August 23, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

levrexa nervous system central acting preparations pharmaceutical